Cetrorelix Acetate Kit
Product Images NDC 60505-6270

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Cetrorelix Acetate (NDC 60505-6270). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cetrorelix 01)

Chemical structure diagram of Cetrorelix Acetate, showing its molecular arrangement with labeled atoms and bonds, including the presence of chlorine (Cl) and acetyl groups (AcOH).*

FDA Label Image

Figure (Cetrorelix 02)

An instructional illustration showing two hands, one holding the other, likely demonstrating a technique related to subcutaneous injection or administration for Cetrorelix Acetate for Injection kit by Apotex Corp.*

FDA Label Image

Figure (Cetrorelix 03)

Cetrorelix acetate for injection kit includes a vial labeled with the medication, a syringe, a needle, and an alcohol swab, displayed on a flat surface. The vial is small and cylindrical, designed for subcutaneous use as part of the prescription drug kit labeled by Apotex Corp.*

FDA Label Image

Figure (Cetrorelix 04)

An instructional illustration showing how to remove a vial's cap. The first part depicts an arrow indicating upward removal of the cap from the vial. The second part shows a hand lifting the cap off the vial. This is likely related to preparation of Cetrorelix Acetate for Injection, KIT for subcutaneous use by Apotex Corp.*

FDA Label Image

Figure (Cetrorelix 05)

An instructional illustration showing the procedure to prepare an injection with a syringe and vial. The graphic includes an angular arrow indicating the motion to attach or remove the syringe needle. This diagram is related to the administration process for Cetrorelix acetate for Injection subcutaneous kit by Apotex Corp.*

FDA Label Image

Figure (Cetrorelix 06)

An instructional diagram depicting a syringe drawing liquid medication from a vial, illustrating preparation for subcutaneous injection.*

FDA Label Image

Figure (Cetrorelix 07)

An instructional illustration showing a hand holding a vial and another hand holding a syringe needle, depicting the process of drawing medication from the vial into the syringe.*

FDA Label Image

Figure (Cetrorelix 08)

An instructional illustration showing a vial connected to a syringe with an arrow pointing downward, indicating the preparation or withdrawal of medication in a subcutaneous injection kit for Cetrorelix acetate by Apotex Corp. The diagram is part of the packaging or usage instructions for the subcutaneous injection kit.*

FDA Label Image

Figure (Cetrorelix 09)

An instructional diagram showing the preparation of an injection using a syringe and vial. The visual depicts a syringe drawing medication from a vial, indicated by arrows illustrating the process steps.*

FDA Label Image

Figure (Cetrorelix 10)

An instructional illustration showing a syringe with a needle, depicting the proper technique for pushing the plunger downward, indicated by an arrow. This image is related to subcutaneous injection procedures for Cetrorelix Acetate for Injection.*

FDA Label Image

Figure (Cetrorelix 11)

An instructional illustration showing hand positioning for subcutaneous injection. The first image depicts a person lifting clothing to expose the injection site on the lower abdomen, and the second image shows a hand preparing or administering an injection into the subcutaneous tissue.*

FDA Label Image

Figure (Cetrorelix 12)

An instructional illustration depicting a hand dropping a hypodermic needle into a biohazard sharps disposal container. Various biohazard disposal items are shown next to the container, indicating safe disposal of injection-related waste.*

FDA Label Image

Principal Display Panel (Carton)

Packaging label for Cetrorelix Acetate for Injection 0.25 mg/vial, a subcutaneous kit by Apotex Corp. The carton indicates it contains one vial with lyophilized powder, one pre-filled syringe with diluent, and needles (20-gauge and 27-gauge). Storage instructions specify refrigeration at 2°C to 8°C (36°F to 46°F). Manufacturer is QILU Pharmaceutical Co., Ltd., China, with Apotex Corp. as labeler.*

FDA Label Image

Principal Display Panel (Tray kit)

Label for Cetrorelix Acetate for Injection 0.25 mg per vial, a kit for subcutaneous use. The label states it contains one vial with lyophilized powder for reconstitution, a pre-filled syringe with diluent, a 20-gauge needle, and a 27-gauge needle. Manufactured by QILU Pharmaceutical Co. for Apotex Corp. The label includes storage instructions and a barcode.*

FDA Label Image

Principal Display Panel (Vial)

Label for Cetrorelix Acetate for Injection 0.25 mg per vial, sterile single-dose vial for subcutaneous use. The label indicates storage instructions, manufacturer details including QILU Pharmaceutical Co., Ltd. (China) and Apotex Corp. (USA), and includes space for lot and expiration dates along with the National Drug Code 60505-6281.*

FDA Label Image

Principal Display Panel (Diluent Syringe)

Label for 1 mL Prefilled Sterile Water for Injection, USP by Apotex Corp. The label includes NDC 60505-6276-0, manufacturer Qilu Pharmaceutical Co., Ltd. in Jinan, China, and features the Apotex Corp. logo with Rx Only designation. Lot and expiration placeholders are shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.